CIK: 0001674712 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 7, 2024
Total Value ($000): $1,221,330 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 8,418,093 | $338,828 | 27.7% | $19.93 | +42.8% | Common | 834203309 |
| — | Gracell Biotechnologies Inc | 9,546,485 | $95,847 | 7.8% | $4.15 | — | SPONSORED ADS | 38406L103 |
| — | Verona Pharma PLC | 4,249,918 | $84,488 | 6.9% | $6.97 | — | SPONSORED ADS | 925050106 |
| HRMY | Harmony Biosciences Holdings Inc | 2,606,247 | $84,182 | 6.9% | $36.16 | -22.8% | Common | 413197104 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $62,837 | 5.1% | $39.31 | -75.9% | Common | 00166B105 |
| — | Avadel Pharmaceuticals PLC | 4,096,428 | $57,842 | 4.7% | $8.54 | — | ADR | 05337M104 |
| GERN | Geron Corp | 24,143,681 | $50,943 | 4.2% | $1.54 | +26.4% | Common | 374163103 |
| TERN | Terns Pharmaceuticals Inc | 6,657,992 | $43,210 | 3.5% | $11.36 | -53.5% | Common | 880881107 |
| VRDN | Viridian Therapeutics Inc | 1,678,207 | $36,551 | 3.0% | $15.47 | +2.1% | Common | 92790C104 |
| TARS | Tarsus Pharmaceuticals Inc | 1,784,006 | $36,126 | 3.0% | $28.48 | -41.4% | Common | 87650L103 |
| — | Icosavax, Inc. | 1,704,568 | $26,864 | 2.2% | $9.93 | — | Common | 45114M109 |
| OLMA | Olema Pharmaceuticals Inc | 1,873,704 | $26,288 | 2.2% | $31.43 | -57.2% | Common | 68062P106 |
| — | Astria Therapeutics Inc | 2,482,727 | $19,067 | 1.6% | $6.12 | — | Common | 04635X102 |
| — | Alpine Immune Sciences Inc | 819,275 | $15,615 | 1.3% | $10.28 | — | Common | 02083G100 |
| — | Tourmaline Bio Inc. | 591,882 | $15,495 | 1.3% | $26.18 | — | Common | 89157D105 |
| CMPS | Compass Pathway PLC | 1,608,000 | $14,070 | 1.2% | $7.40 | — | SPONSORED ADS | 20451W101 |
| DYN | Dyne Therapeutics Inc | 1,035,136 | $13,767 | 1.1% | $16.36 | -40.3% | Common | 26818M108 |
| COGT | Cogent Biosciences Inc | 2,244,941 | $13,200 | 1.1% | $8.55 | -10.3% | Common | 19240Q201 |
| VSTM | Verastem Inc | 1,538,461 | $12,523 | 1.0% | $6.94 | +3.5% | Common | 92337C203 |
| CRNX | Crinetics Pharmaceuticals Inc | 350,000 | $12,453 | 1.0% | $20.61 | +48.8% | Common | 22663K107 |
| IOBT | IO Biotech Inc | 6,173,439 | $11,606 | 1.0% | $5.62 | -78.8% | Common | 449778109 |
| ZLAB | Zai Lab Ltd | 411,677 | $11,251 | 0.9% | $45.03 | — | ADR | 98887Q104 |
| APGE | Apogee Therapeutics Inc | 400,000 | $11,176 | 0.9% | $22.03 | -9.0% | Common | 03770N101 |
| KALV | KalVista Pharmaceuticals Inc. | 856,008 | $10,486 | 0.9% | $15.45 | -41.1% | Common | 483497103 |
| — | Genetron Holdings Ltd | 2,708,056 | $9,966 | 0.8% | $3.68 | — | ADS | 37186H209 |
| SERA | Sera Prognostics Inc | 1,650,440 | $9,870 | 0.8% | $10.38 | -72.0% | Common | 81749D107 |
| SVRA | Savara Inc | 2,088,323 | $9,815 | 0.8% | $3.59 | +6.8% | Common | 805111101 |
| SLN | Silence Therapeutics PLC | 510,204 | $8,862 | 0.7% | $17.37 | — | ADS | 82686Q101 |
| — | Allakos Inc | 2,988,000 | $8,157 | 0.7% | $6.12 | — | Common | 01671P100 |
| PHVS | Pharvaris NV | 285,000 | $7,994 | 0.7% | $20.23 | 0.0% | Common | N69605108 |
| ORIC | Oric Pharmaceuticals Inc | 849,681 | $7,817 | 0.6% | $8.11 | -10.9% | Common | 68622P109 |
| — | Rayzebio Inc | 110,581 | $6,875 | 0.6% | $22.20 | — | Common | 75525N107 |
| ENGN | Engene Holdings Inc. | 678,705 | $6,264 | 0.5% | $10.40 | 0.0% | Common | 29286M105 |
| CMPX | Compass Therapeutics Inc | 3,556,023 | $5,547 | 0.5% | $3.60 | -51.9% | Common | 20454B104 |
| IOVA | Iovance Biotherapeutics Inc | 655,057 | $5,326 | 0.4% | $18.48 | -71.7% | Common | 462260100 |
| TIL | Instil Bio Inc | 624,340 | $4,757 | 0.4% | $7.23 | 0.0% | Common | 45783C200 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $4,205 | 0.3% | $40.33 | -34.2% | Common | 04280A100 |
| — | Bolt Therapeutics Inc | 3,521,291 | $3,944 | 0.3% | $32.91 | — | Common | 097702104 |
| DCTH | Delcath Systems, Inc. | 855,191 | $3,558 | 0.3% | $5.69 | -42.5% | Common | 24661P807 |
| RZLT | Rezolute Inc | 3,242,842 | $3,219 | 0.3% | $1.28 | -28.2% | Common | 76200L309 |
| — | Unicycive Therapeutics | 3,470,152 | $3,011 | 0.2% | $0.86 | — | Common | 90466Y103 |
| — | DBV Technologies SA | 2,708,875 | $2,581 | 0.2% | $1.77 | — | SPONSORED ADS | 23306J101 |
| — | Aligos Therapeutics Inc | 3,547,030 | $2,355 | 0.2% | $27.65 | — | Common | 01626L105 |
| CDXS | Codexis, Inc | 388,144 | $1,184 | 0.1% | $13.98 | -84.6% | Common | 192005106 |
| WHWK | Aadi Bioscience Inc | 509,572 | $1,029 | 0.1% | $30.48 | -86.2% | Common | 00032Q104 |
| — | Homology Medicines, Inc. | 370,068 | $225 | 0.0% | $15.54 | — | Common | 438083107 |
| — | Precision Biosciences Inc | 140,255 | $51 | 0.0% | $6.03 | — | Common | 74019P108 |